Kir (cocktail) - Wikipedia Kir is a French cocktail made with a measure of crème de cassis (blackcurrant liqueur) topped up with white wine In France it is usually drunk as an apéritif before a meal or snack
What Is Kir? - Taste France Magazine The Kir cocktail, formerly called the blanc-cassis, was named after Félix Kir, the former mayor of Dijon The drink became quite popular during World war II, as it was often served to international guests at meetings and gatherings
Kir Cocktail Recipe | How to Make the perfect Kir The cocktail is a simple yet elegant combination of dry white wine and crème de cassis, a blackcurrant liqueur Originally, the cocktail was made with Bourgogne Aligoté, a white wine from Burgundy The Kir Royale, a variation of the Kir, is made with Champagne instead of white wine
The Classic Kir Cocktail - Wine Enthusiast Despite its simple recipe, the Kir cocktail’s roots are highly debated The drink gets its name from Félix Kir, who in the early 20th century was mayor of Dijon, France Some believe Kir offered the cocktail to foreign visitors, who brought the recipe back home
Kir Royale Cocktail Recipe - Liquor. com The Kir Royale is a take on the Kir, a popular French drink combining dry white Burgundian wine with crème de cassis that dates back to the 19th century and was further popularized after World War II
Kir Recipe - NYT Cooking A classic kir is made with aligoté wine and crème de cassis (black currant liqueur), both of which come from the Burgundy region of France Once you have the classic down (a glass of white wine
How to Make a Kir: A Simple Cocktail Recipe The kir is one of the easiest cocktail recipes to make, yet it brings a touch of sophistication to any gathering Its deep berry notes combined with crisp white wine create a drink that’s both refreshing and flavorful
Team - Verismo Therapeutics: Defining a New Generation of KIR-based CAR . . . Verismo was founded by the inventors of Kymriah™, the first-ever FDA-approved CAR T cell therapy This same team saw an opportunity to overcome the limitations found in first-generation CAR T therapies through the use of killer immunoglobulin-like (KIR) receptors in a multi-chain KIR-CAR platform